Cryptosporidium virulence determinants -: are we there yet?

被引:54
作者
Okhuysen, PC
Chappell, CL
机构
[1] Univ Texas, Hlth Sci Ctr, Houston Med Sch, Dept Med,Div Infect Dis, Houston, TX 77030 USA
[2] Univ Texas, Hlth Sci Ctr, Houston Med Sch, Sch Publ Hlth, Houston, TX 77030 USA
关键词
Cryptosporidium; virulence; diarrhoea;
D O I
10.1016/S0020-7519(01)00356-3
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Exposure to Cryptosporidium parvum in healthy individuals results in transient infection that may be asymptomatic or can result in self-limited diarrhoea. In contrast, acquired immune deficiency syndrome patients with cryptosporidiosis can experience severe manifestations of disease. Volunteer studies have demonstrated that as few as 10 oocysts can cause infection in otherwise healthy adults and that isolates from geographically diverse regions differ in infectivity and, perhaps, virulence. Variability in isolate pathogenicity and infectivity has also been seen in bovine and murine models, respectively. Furthermore, isolate specific differences in protein composition and in host immunoreactivity have been observed. The molecular basis for differences in pathogenicity is not understood. Determining which factors are responsible for host selectivity and for the initiation, establishment, and perpetuation of infection with Cryptosporidium is hey to rational drug design and vaccine development. To date, no specific virulence factors have been unequivocally shown to individually cause direct or indirect damage to host tissues nor have mutant strains been produced that could prove that particular deletions result in less virulent strains. Nevertheless, a number of candidate molecules have been identified by immunological and molecular methods. Here, we review the salient characteristics of some of these putative virulence determinants, including molecules that are involved in adhesion, protein degradation and the modulation of the host responses. (C) 2002 Australian Society for Parasitology Inc. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:517 / 525
页数:9
相关论文
共 82 条
[41]   Molecular characterization of Cryptosporidium from various hosts [J].
Morgan, UM ;
Sargent, KD ;
Deplazes, P ;
Forbes, DA ;
Spano, F ;
Hertzberg, H ;
Elliot, A ;
Thompson, RCA .
PARASITOLOGY, 1998, 117 :31-37
[42]   Declining CD4+ T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea:: Results of a 3-year longitudinal study [J].
Navin, TR ;
Weber, R ;
Vugia, DJ ;
Rimland, D ;
Roberts, JM ;
Addiss, DG ;
Visvesvara, GS ;
Wahlquist, SP ;
Hogan, SE ;
Gallagher, LE ;
Juranek, DD ;
Schwartz, DA ;
Wilcox, CM ;
Stewart, JM ;
Thompson, SE ;
Bryan, RT .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1999, 20 (02) :154-159
[43]   Receptor ligand interactions between Cryptosporidium parvum and the surface of the host cell [J].
Nesterenko, MV ;
Woods, K ;
Upton, SJ .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1999, 1454 (02) :165-173
[44]  
NESTERENKO MV, 1995, MICROBIOS, V83, P77
[45]   Virulence of three distinct Cryptosporidium parvum isolates for healthy adults [J].
Okhuysen, PC ;
Chappell, CL ;
Crabb, JH ;
Sterling, CR ;
DuPont, HL .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) :1275-1281
[46]   ARGININE AMINOPEPTIDASE, AN INTEGRAL MEMBRANE-PROTEIN OF THE CRYPTOSPORIDIUM-PARVUM SPOROZOITE [J].
OKHUYSEN, PC ;
DUPONT, HL ;
STERLING, CR ;
CHAPPELL, CL .
INFECTION AND IMMUNITY, 1994, 62 (10) :4667-4670
[47]   Cryptosporidium parvum metalloaminopeptidase inhibitors prevent in vitro excystation [J].
Okhuysen, PC ;
Chappell, CL ;
Kettner, C ;
Sterling, CR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2781-2784
[48]   Genetic polymorphism among Cryptosporidium parvum isolates: Evidence of two distinct human transmission cycles [J].
Peng, MM ;
Xiao, LH ;
Freeman, AR ;
Arrowood, MJ ;
Escalante, AA ;
Weltman, AC ;
Ong, CSL ;
MacKenzie, WR ;
Lal, AA ;
Beard, CB .
EMERGING INFECTIOUS DISEASES, 1997, 3 (04) :567-573
[49]   CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages [J].
Perkins, ME ;
Riojas, YA ;
Wu, TW ;
Le Blancq, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5734-5739
[50]   KINETICS OF CRYPTOSPORIDIUM-PARVUM SPOROZOITE NEUTRALIZATION BY MONOCLONAL-ANTIBODIES, IMMUNE BOVINE SERUM, AND IMMUNE BOVINE COLOSTRUM [J].
PERRYMAN, LE ;
RIGGS, MW ;
MASON, PH ;
FAYER, R .
INFECTION AND IMMUNITY, 1990, 58 (01) :257-259